Ahrens M, Escudier B, Haanen J, Gross-Goupil M, Boleti E, Gravis G, Grimm MO, Negrier S, Bedke J, Barthelemy P, Castellano D, Mellado B, Ivanyi P, Rottey S, Florcken A, Maroto JP, Rodriguez SC, Oosting SF, Panic A, Zschabitz S, Boegemann M, Kopecky J, Deckbar D, Hartmann A, Bergmann L (2022)
Publication Type: Conference contribution
Publication year: 2022
Publisher: KARGER
City/Town: BASEL
Pages Range: 317-318
Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT
APA:
Ahrens, M., Escudier, B., Haanen, J., Gross-Goupil, M., Boleti, E., Gravis, G.,... Bergmann, L. (2022). A randomized phase II trial of ipilimumab and nivolumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNNIFORECAST). In ONCOLOGY RESEARCH AND TREATMENT (pp. 317-318). BASEL: KARGER.
MLA:
Ahrens, M., et al. "A randomized phase II trial of ipilimumab and nivolumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNNIFORECAST)." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2022. 317-318.
BibTeX: Download